SH Snyder, CD Ferris - American Journal of Psychiatry, 2000 - Am Psychiatric Assoc
OBJECTIVE: The purpose of this review is to integrate insights regarding novel neurotransmitters or neuromodulators of neuropsychiatric significance. METHOD: Evolving …
K Hamase, A Morikawa, K Zaitsu - Journal of chromatography B, 2002 - Elsevier
Substantial amounts of d-amino acids are present in mammalian tissues; their function, origin and relationship between pathophysiological processes have been of great interest …
SA Fuchs, R Berger, LWJ Klomp… - Molecular genetics and …, 2005 - Elsevier
Recent evidence has shown that d-amino acids are present in animals and humans in high concentrations and fulfill specific biological functions. In the central nervous system, two d …
CA Weatherly, S Du, C Parpia, PT Santos… - ACS chemical …, 2017 - ACS Publications
The l-enantiomer is the predominant type of amino acid in all living systems. However, d- amino acids, once thought to be “unnatural”, have been found to be indigenous even in …
Y Nagata, H Homma, JA Lee, K Imai - FEBS letters, 1999 - Elsevier
d-Aspartate increases human chorionic gonadotropin-induced testosterone production in purified rat Leydig cells. l-Aspartate, d-, l-glutamate or d-, l-asparagine could not substitute …
N Ota, T Shi, JV Sweedler - Amino acids, 2012 - Springer
Abstract d-Aspartate (d-Asp) is an endogenous amino acid in the central nervous and reproductive systems of vertebrates and invertebrates. High concentrations of d-Asp are …
D‐Aspartic acid (D‐Asp) is present in invertebrate and vertebrate neuroendocrine tissues' where it carries out important physiological functions and is implicated in nervous system …
L Piubelli, G Murtas, V Rabattoni… - Journal of Alzheimer's …, 2021 - content.iospress.com
Abstract Alzheimer's disease (AD), the main cause of dementia worldwide, is characterized by a complex and multifactorial etiology. In large part, excitatory neurotransmission in the …
SG Snowden, AA Ebshiana, A Hye… - Journal of …, 2019 - content.iospress.com
Background: Cholinesterase inhibitors represent three of the four treatments for Alzheimer's disease (AD), and target the pathological reduction of acetylcholine levels. Here we aimed …